C4PAIN ApS
CVR 32292402 · Private limited company (ApS) · Active · Low risk
C4PAIN ApS is a Private limited company (ApS), founded on , based in Aalborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 16 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 4.2m and a net result of DKK 186k.
Bankruptcy risk for C4PAIN ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32292402
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (17 years)
- Address
- M.A. Schultz Vej 7
9000 Aalborg - Municipality
- Aalborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 75k
- Employees
- 0 (2014)
- Auditor
- Redmark, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 95.4% |
| Current ratio | 2,169% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 159k | DKK 1.3m |
| Net profit | DKK 186k | DKK 1.1m |
| Equity | DKK 4.2m | DKK 4.0m |
| Total assets | DKK 4.4m | DKK 4.4m |
| Cash | DKK 38k | – |
| Short-term debt | DKK 201k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 120 | ||
| 1 Jan 2024 – 31 Dec 2024 | 174 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 193 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 189 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 181 | ||
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 1 Jan 2017 – 31 Dec 2017 | 152 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 152 | ||
| 1 Jan 2014 – 31 Dec 2014 | 155 | ||
| 1 Jan 2013 – 31 Dec 2013 | 162 | ||
| 1 Jan 2012 – 31 Dec 2012 | 155 | ||
| 1 Jan 2011 – 31 Dec 2011 | 157 | ||
| 21 Jul 2009 – 31 Dec 2010 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Lars Arendt-Nielsen | ||
| Board | Claus Henrik Christiansen | ||
| Board | Henrik Bernt Sanders | ||
| Board | Charles-Hervé Girsault | ||
| Owner (100%) | BIO-MEDICAL CONSULT HOLDING ApS | Current | |
| Owner (67%) | Lars Arendt-Nielsen | ||
| Owner (100%) | ANESIDORA AALBORG ApS | ||
| Auditor | Brink Larse /Athos, Statsautoriseret Revisionsvirksomhed I/S | ||
| Auditor | Revisionsfirmaet Peter Kristensen | ||
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | ||
| Founder | Henrik Bernt Sanders | Current | |
| Founder | KARSDAL CONSULTING ApS | Current | |
| Founder | BIO-MEDICAL CONSULT HOLDING ApS | Current | |
| Founder | PARCON 2008 ApS | Current | |
| Founder | Sunshine Enterprise Holding A/S | Current |
Address history (2 moves)
| M.A. Schultz Vej 7, 9000 Aalborg | |
| Hobrovej 42D, 3., 9000 Aalborg | |
| Ballerup Byvej 222, 2750 Ballerup |
Employees per year
Other companies at the same address
- ANESIDORA AALBORG ApS Fusioneret
- BIO-MEDICAL CONSULT ApS Fusioneret
- BIO-MEDICAL CONSULT HOLDING ApS Active
Similar companies in Aalborg
- Neurometa Therapeutics ApS Aalborg Øst
- Biogenity ApS Aalborg Øst
- 2A Pharma ApS Aalborg Øst
- Methyl Detect ApS Aalborg Øst
- EEGTRAINING NORD ApS Vestbjerg
- DNASENSE ApS Aalborg Øst
- OLE USSING ApS Aalborg
- REDO-Neurosystems ApS Aalborg
- 2N Pharma ApS Aalborg Øst
- ClearDynamic ApS Nørresundby
- The Froglet IVS Aalborg
- EMProS IVS Gistrup
Questions and answers about C4PAIN ApS
Has C4PAIN ApS gone bankrupt?
No, C4PAIN ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of C4PAIN ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of C4PAIN ApS?
C4PAIN ApS most recently used Redmark, Godkendt Revisionspartnerselskab.
When was C4PAIN ApS founded?
C4PAIN ApS was founded on 21 July 2009.
What is the equity of C4PAIN ApS?
Equity was DKK 4.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.